Additionally, we found that hepcidin expression was negatively correlated with temozolomide sensitivity, indicating that the higher the expression of hepdicin, the lower the IC50 value of temozolomide in brain tumors based on the GDSC database using the R package pRRophetic (Supplementary Figures S7A, B). This evidence concerns the gene HAMP and brain neoplasm.